HMG-CoA reductase is not the site of the primary defect in phytosterolemia.
Phytosterolemia is an autosomal recessive disorder characterized by the excessive absorption, reduced excretion, and consequent high tissue and plasma levels of plant sterols, by the presence of tendon xanthomas, and by premature atherosclerosis. Low HMG-CoA reductase (HRase) activity and mass have been reported in liver and mononuclear leucocytes and low mRNA levels in liver from phytosterolemic subjects. These results led to the proposal that the primary defect in this condition involves the HRase gene locus. We examined this hypothesis in phytosterolemic subjects and heterozygous parents from four unrelated families. A variable number tandem repeat (VNTR) polymorphism of the HRase gene in the three informative families and a ScrFI restriction fragment length polymorphism (RFLP) within intron 2 of the gene in one of these families, segregated independently of the disease phenotype. Biological parentage was confirmed in the family in whom both polymorphisms failed to segregate with the disorder. These results conclusively exclude the HRase gene locus as the site of the primary defect in phytosterolemia. The study was extended by examining plasma levels of mevalonic acid and lathosterol, both markers of cholesterol biosynthesis, in response to cholestyramine, a bile acid sequestrant that is known to up-regulate HRase. Oral administration of cholestyramine resulted in a substantial (7.7-fold) increase in mevaIonic acid levels in two phytosterolemic subjects, compared with a 2.2-fold rise in their obligate heterozygote parents and a 2.3-fold increase in three healthy control subjects. The lathosterol/cholesterol (L/C) ratio showed a quantitatively similar response. Baseline levels of mevalonate and the L/C ratio were low in the phytosterolemic patients in conformity with reports of reduced cholesterol biosynthesis and HRase activity in this disorder. These functional data provide support for the concept that the primary defect in phytosterolemia does not affect a trans gene locus responsible for the constitutive expression or regulation of HMG-CoA reductase.
Berger
G M
GM
Department of Chemical Pathology, University of Natal Medical School, Durban, South Africa.
Pegoraro
R J
RJ
Patel
S B
SB
Naidu
P
P
Rom
L
L
Hidaka
H
H
Marais
A D
AD
Jadhav
A
A
Naoumova
R P
RP
Thompson
G R
GR
D000293:Adolescent; D000328:Adult; D001161:Arteriosclerosis / Q000150:complications / Q000201:enzymology / Q000235:genetics; D002648:Child; D002792:Cholestyramine Resin; D005260:Female; D008040:Genetic Linkage; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000502:physiology*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D018598:Minisatellite Repeats; D010375:Pedigree; D010840:Phytosterols / Q000097:blood*; D011110:Polymorphism, Genetic; D014973:Xanthomatosis / Q000150:complications / Q000201:enzymology / Q000235:genetics
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010840:Phytosterols; D002792:Cholestyramine Resin; D006903:Hydroxymethylglutaryl CoA Reductases